FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009212934> ?p ?o ?g. }

• W2009212934 abstract "The results of a multicenter phase II study investigating carboplatin and pegylated liposomal doxorubicin (PLD) in patients with recurrent/metastatic uterine and cervical malignancies (UCM) are presented here. Fifty-three subjects with measurable, untreated, advanced UCM were enrolled. Fifty-one were evaluable for response. Prior combined-modality treatment was permitted if a component of primary therapy. Patients received carboplatin AUC = 5 with PLD 35 mg/m(2) intravenously once every 4 weeks. Overall response rate was 33% (35% stable disease). Overall survival (OS) at six months was 86% (95% CI 76%-96%). Six-month progression-free survival (PFS) was 43% (95% CI 30%-57%). Median PFS was 22.9 weeks (range 16.0-35.3) and median OS was 49.1 weeks (range 41.4-75.1). The most frequent grade 3-4 nonhematological adverse events were: abdominal pain (n = 7), fatigue (4), vomiting (4), nausea (3), and shortness of breath (3). There was 1 report of grade 3 hand-foot syndrome and none of grade 4. Twelve patients had first infusion reactions with only 1 discontinuing treatment. Grade 3-4 neutropenia occurred in 26/230 cycles (11.3%). There were no treatment-related deaths. The combination of carboplatin and PLD is well tolerated with sufficient activity to justify additional evaluation in clinical trials and might be suited to the addition of a taxane." @default.
• W2009212934 created "2016-06-24" @default.
• W2009212934 creator A5017602940 @default.
• W2009212934 creator A5018001559 @default.
• W2009212934 creator A5032075908 @default.
• W2009212934 creator A5034199946 @default.
• W2009212934 creator A5035033331 @default.
• W2009212934 creator A5039497051 @default.
• W2009212934 creator A5047689900 @default.
• W2009212934 creator A5048415030 @default.
• W2009212934 creator A5076197407 @default.
• W2009212934 creator A5078987114 @default.
• W2009212934 creator A5081079200 @default.
• W2009212934 date "2005-09-01" @default.
• W2009212934 modified "2023-10-16" @default.
• W2009212934 title "Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies" @default.
• W2009212934 cites W1526057084 @default.
• W2009212934 cites W1589920570 @default.
• W2009212934 cites W1865453869 @default.
• W2009212934 cites W1918322381 @default.
• W2009212934 cites W1936102867 @default.
• W2009212934 cites W1960327677 @default.
• W2009212934 cites W1964577828 @default.
• W2009212934 cites W1972536070 @default.
• W2009212934 cites W1975298683 @default.
• W2009212934 cites W1984351126 @default.
• W2009212934 cites W1986822666 @default.
• W2009212934 cites W1989339760 @default.
• W2009212934 cites W1990983926 @default.
• W2009212934 cites W2013103474 @default.
• W2009212934 cites W2013981808 @default.
• W2009212934 cites W2014324176 @default.
• W2009212934 cites W2019549947 @default.
• W2009212934 cites W2021949334 @default.
• W2009212934 cites W2041901579 @default.
• W2009212934 cites W2042892958 @default.
• W2009212934 cites W2045920619 @default.
• W2009212934 cites W2051119562 @default.
• W2009212934 cites W2051787604 @default.
• W2009212934 cites W2057051880 @default.
• W2009212934 cites W2058066180 @default.
• W2009212934 cites W2068953119 @default.
• W2009212934 cites W2077469663 @default.
• W2009212934 cites W2079400192 @default.
• W2009212934 cites W2083168801 @default.
• W2009212934 cites W2083717566 @default.
• W2009212934 cites W2099763306 @default.
• W2009212934 cites W2116237162 @default.
• W2009212934 cites W2116996913 @default.
• W2009212934 cites W2132587696 @default.
• W2009212934 cites W2147762911 @default.
• W2009212934 cites W2154919109 @default.
• W2009212934 cites W2159905203 @default.
• W2009212934 cites W2165837635 @default.
• W2009212934 cites W2171548026 @default.
• W2009212934 cites W2172342370 @default.
• W2009212934 cites W2243803571 @default.
• W2009212934 cites W2285731702 @default.
• W2009212934 cites W2316012460 @default.
• W2009212934 doi "https://doi.org/10.1111/j.1525-1438.2005.00139.x" @default.
• W2009212934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16174227" @default.
• W2009212934 hasPublicationYear "2005" @default.
• W2009212934 type Work @default.
• W2009212934 sameAs 2009212934 @default.
• W2009212934 citedByCount "10" @default.
• W2009212934 countsByYear W20092129342012 @default.
• W2009212934 countsByYear W20092129342014 @default.
• W2009212934 countsByYear W20092129342016 @default.
• W2009212934 countsByYear W20092129342020 @default.
• W2009212934 countsByYear W20092129342021 @default.
• W2009212934 crossrefType "journal-article" @default.
• W2009212934 hasAuthorship W2009212934A5017602940 @default.
• W2009212934 hasAuthorship W2009212934A5018001559 @default.
• W2009212934 hasAuthorship W2009212934A5032075908 @default.
• W2009212934 hasAuthorship W2009212934A5034199946 @default.
• W2009212934 hasAuthorship W2009212934A5035033331 @default.
• W2009212934 hasAuthorship W2009212934A5039497051 @default.
• W2009212934 hasAuthorship W2009212934A5047689900 @default.
• W2009212934 hasAuthorship W2009212934A5048415030 @default.
• W2009212934 hasAuthorship W2009212934A5076197407 @default.
• W2009212934 hasAuthorship W2009212934A5078987114 @default.
• W2009212934 hasAuthorship W2009212934A5081079200 @default.
• W2009212934 hasConcept C126322002 @default.
• W2009212934 hasConcept C141071460 @default.
• W2009212934 hasConcept C197934379 @default.
• W2009212934 hasConcept C2776694085 @default.
• W2009212934 hasConcept C2777063308 @default.
• W2009212934 hasConcept C2778239845 @default.
• W2009212934 hasConcept C2780580376 @default.
• W2009212934 hasConcept C2780852908 @default.
• W2009212934 hasConcept C2781451048 @default.
• W2009212934 hasConcept C31760486 @default.
• W2009212934 hasConcept C71924100 @default.
• W2009212934 hasConcept C90924648 @default.
• W2009212934 hasConceptScore W2009212934C126322002 @default.
• W2009212934 hasConceptScore W2009212934C141071460 @default.
• W2009212934 hasConceptScore W2009212934C197934379 @default.
• W2009212934 hasConceptScore W2009212934C2776694085 @default.
• W2009212934 hasConceptScore W2009212934C2777063308 @default.
• W2009212934 hasConceptScore W2009212934C2778239845 @default.

• next